Vaddi Krishna

CIK 00018246331 companyWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001824633

Recent Transactions

27 trades

Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-25$0.69/sh+675,000→ 1,999,296 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-21$0.73/sh+15,000→ 1,324,296 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-20$0.73/sh+5,416→ 1,309,296 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-17$0.75/sh+9,106→ 1,303,880 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-14$0.75/sh+29,999→ 1,294,774 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-13$0.72/sh+50,000→ 1,264,775 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2025-03-12$0.71/sh+47,500→ 1,214,775 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2025-02-04+496,000→ 496,000 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2024-12-31$1.21/sh+5,000→ 142,553 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2024-12-30$1.20/sh+10,000→ 137,553 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2024-12-19$0.89/sh+6,888→ 127,553 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2024-12-18$0.93/sh+100,000→ 1,167,275 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2024-03-01+425,000→ 425,000 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2023-05-25$5.31/sh+900→ 1,067,275 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2023-05-24$5.01/sh+1,000→ 1,066,375 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2023-05-23$5.63/sh+11,856→ 1,065,375 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2023-02-07+330,000→ 330,000 total
Purchase
Prelude Therapeutics Inc$PRLD
Common Stock
2022-12-20$5.13/sh+19,188→ 120,665 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2022-02-15+327,900→ 327,900 total
Award
Prelude Therapeutics Inc$PRLD
Common Stock
2021-12-13$12.13/sh+8,000→ 1,053,519 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-20+285,800→ 285,800 total
Conversion
Prelude Therapeutics Inc$PRLD
Series A Preferred Stock
2020-09-29−101,477→ 0 total
Conversion
Prelude Therapeutics Inc$PRLD
Series A Preferred Stock
2020-09-29−32,876→ 0 total
Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2020-09-29+32,876→ 551,776 total
Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2020-09-29+32,876→ 551,774 total
Conversion
Prelude Therapeutics Inc$PRLD
Series A Preferred Stock
2020-09-29−32,876→ 0 total
Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2020-09-29+101,477→ 101,477 total

Companies

Prelude Therapeutics Inc
Director, CEO
$PRLD

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805

View on SEC.gov